Leading technology companies and U.S. government agencies have announced a new $1.8 billion initiative designed to accelerate the application of artificial intelligence in biological research.
The program will create extensive datasets detailing cellular activity and develop advanced AI models capable of predicting and simulating biological processes. Scientists say the technology could help speed up drug discovery by identifying the most promising experiments before they are carried out in laboratories.
